BA
OMCL icon

Boston Advisors’s Omnicell OMCL Stock Holding History

Boston Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,045
Closed -$419K – 696
2016
Q1 		$419K Buy
15,045
+90
+0.6% +$2.47K 0.01% 501
2015
Q4 		$465K Hold
14,955
– – 0.01% 478
2015
Q3 		$465K Sell
14,955
-5,171
-26% -$185K 0.02% 541
2015
Q2 		$759K Buy
20,126
+910
+5% +$33.2K 0.03% 348
2015
Q1 		$674K Buy
19,216
+8,095
+73% +$267K 0.03% 380
2014
Q4 		$368K Hold
11,121
– – 0.02% 411
2014
Q3 		$304K Sell
11,121
-1,200
-10% -$32.9K 0.01% 459
2014
Q2 		$354K Sell
12,321
-605
-5% -$16.3K 0.02% 435
2014
Q1 		$370K Buy
+12,926
New +$354K 0.02% 405

Other funds holding OMCL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Advisors's OMCL Position: Q2 2016 in Review

Boston Advisors sold out of Omnicell (OMCL) in Q2 2016, closing a stake of 15,045 shares — an estimated $419K sold.

Boston Advisors first reported a position in OMCL in Q1 2014 and held it in 9 quarters. The position peaked at $759K in Q2 2015. 198 funds tracked by Wall St. Rank hold OMCL as of Q2 2016.

  • Boston Advisors reported no remaining Omnicell position as of Q2 2016 after selling out during the quarter.
  • Boston Advisors sold 15,045 Omnicell shares in Q2 2016, an estimated $419K.
  • Boston Advisors first reported a position in Omnicell in Q1 2014 and held it in 9 quarters.
  • Boston Advisors's Omnicell position peaked at $759K in Q2 2015.
  • 198 funds tracked by Wall St. Rank held Omnicell as of Q2 2016.

Based on Boston Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.